{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:21:01Z","timestamp":1788556861097,"version":"build-2803163510"},"reference-count":212,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Young patients with lung cancer represent a distinct population, with unique disease and treatment-related characteristics, as well as psychosocial and survivorship needs. Nevertheless, this population remains vastly understudied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We review the unique clinicopathological characteristics and needs of young patients with lung cancer, including topics such as incidence rates, diagnostic challenges, genomics, treatment patterns and outcomes, psychosocial needs, fertility and sexual health, and palliative care. We discuss emerging and understudied data, provide recommendations on aspects in which future research is warranted, and advocate for actionable strategies that multi-disciplinary healthcare teams may adopt to provide more personalized and equitable care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Though epidemiological trends suggest an overall decrease in lung cancer incidence among all age groups, recent increasing incidences have been reported among certain young populations in the U.S., as well as among Hispanic women and women in certain European countries. Young patients are significantly more likely to be female or Asian\/Pacific Islander, have no tobacco use history, metastasis to the brain, and a higher frequency of somatic mutations or rearrangements. Diagnostic delays pose a considerable concern to young patients with lung cancer and may contribute to how these patients are more likely to be diagnosed with advanced disease than their older counterparts. However, young patients demonstrate improved survival compared to older patients, underscoring the importance of survivorship care. Young patients are more likely to be diagnosed at a disruptive time in their lives, rendering them with distinct psychosocial needs and financial toxicity. Future data on treatment-related effects on fertility and sexual health for young patients is warranted, as is the data related to complementary medicine use. Training in palliative care and promoting a positive attitude towards supportive care is also essential.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Young patients with lung cancer represent a distinct patient population, necessitating disease management that is markedly different from that of older patients with lung cancer. Future research, some of which are highlighted by this Review, will aid in elucidating risk factors, survival rates, and clinical, genomic, and histopathological characteristics of young-onset lung cancer to improve screening, early detection, prevention, and treatment of this understudied population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1570143","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:28:43Z","timestamp":1750915723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Young lung cancer: from diagnosis to survivorship"],"prefix":"10.3389","volume":"15","author":[{"given":"Narjust","family":"Florez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"LoPiccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Ricciuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka","family":"Fakorede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Mantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Olazagasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishwant","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa","family":"Kanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Decat","family":"Bergerot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Bye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice T.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"B1","volume-title":"Key Statistics for Lung Cancer","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics","volume":"2025","author":"Siegel","year":"2025","journal-title":"CA: A Cancer J Clin"},{"key":"B3","article-title":"World lung cancer day fact sheet","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa1715907","article-title":"Higher lung cancer incidence in young women than young men in the United States","volume":"378","author":"Jemal","year":"2018","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v121:2","article-title":"Trends in lung cancer among young European women: the rising epidemic in France and Spain","volume":"121","author":"Levi","year":"2007","journal-title":"Int J Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1177482","article-title":"The incidence and mortality of lung cancer in China: a trend analysis and comparison with G20 based on the Global Burden of Disease Study 2019","volume":"13","author":"Long","year":"2023","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101030","article-title":"The trends in lung cancer prevalence, incidence, and survival in Hong Kong over the past two decades (2002\u20132021): a population-based study","volume":"45","author":"Au","year":"2024","journal-title":"Lancet Regional Health\u2013Western Pacific"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00113","article-title":"Trends and characteristics of young non-small cell lung cancer patients in the United States","volume":"5","author":"Thomas","year":"2015","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.12.655","article-title":"Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: a global analysis","volume":"161","author":"Huang","year":"2022","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00844-0","article-title":"Lung cancer in patients who have never smoked\u2014An emerging disease","volume":"21","author":"LoPiccolo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B11","article-title":"Lung and bronchus recent trends in SEER age-Adjusted incidence rates, 2000-2021","year":""},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.08.022","article-title":"An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP)","volume":"113","author":"Corrales-Rodr\u00edguez","year":"2017","journal-title":"Lung Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.7150\/jca.27490","article-title":"Lung cancer in young adults aged 35 years or younger: a full-scale analysis and review","volume":"10","author":"Liu","year":"2019","journal-title":"J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00408-019-00294-5","article-title":"Lung cancer in the young","volume":"198","author":"Galvez-Nino","year":"2020","journal-title":"Lung"},{"key":"B15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ijc.v156.3","article-title":"Lung cancer incidence rates in young women and men by state in the United States","volume":"156","author":"Jemal","year":"2025","journal-title":"Int J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0077-2024","article-title":"Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis","volume":"33","author":"Possenti","year":"2024","journal-title":"Eur Respir Rev"},{"key":"B17","volume-title":"Oral Contraceptives and Cancer Risk","year":"2018"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1016\/j.jtho.2018.08.285","article-title":"OA09. 06 molecular alterations and estimated indoor radon in NSCLC patients from the French National Cancer Institute registry: Radon France study","volume":"13","author":"Mezquita","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.065","article-title":"OA13. 04 prevalence of molecular alterations in NSCLC and Estimated Indoor radon in Europe: RADON EUROPE Study","volume":"17","author":"Garcia","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B20","article-title":"Why is colorectal cancer rising rapidly among young adults","year":"2020"},{"key":"B21","article-title":"Lung cancer survival rates","year":"2024"},{"key":"B22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3978\/j.issn.2072-1439.2011.01.01","article-title":"Delays in the diagnosis of lung cancer","volume":"3","author":"Ellis","year":"2011","journal-title":"J Thorac Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1515\/dx-2019-0019","article-title":"Serious misdiagnosis-related harms in malpractice claims: the \u201cBig Three\u201d\u2013vascular events, infections, and cancers","volume":"6","author":"Newman-Toker","year":"2019","journal-title":"Diagnosis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"ix147","DOI":"10.1016\/S0923-7534(21)00616-5","article-title":"458P Lung cancer diagnostic delay secondary to misdiagnosis with lung tuberculosis in Dr. Moewardi Public Hospital pulmonary ward Surakarta","volume":"27","author":"Rima","year":"2016","journal-title":"Ann Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-020-1105-2","article-title":"Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report","volume":"20","author":"Shin","year":"2020","journal-title":"BMC Pulmonary Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1572359","article-title":"Infection or Malignancy? Malignant pulmonary mass mimicking pneumonia","volume":"2","author":"Evman","year":"2016","journal-title":"Surg J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4103\/singaporemedj.SMJ-2023-007","article-title":"Lung cancer screening for never smokers: current evidence and future directions","volume":"10","author":"See","year":"2024","journal-title":"Singapore Med J"},{"key":"B28","volume-title":"Lung Cancer: Screening","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127717","article-title":"Age and gender variations in cancer diagnostic intervals in 15 cancers: analysis of data from the UK Clinical Practice Research Datalink","volume":"10","author":"Din","year":"2015","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.15_suppl.e17740","article-title":"Delays in the diagnosis and treatment of women with lung cancer: A systematic analysis","volume":"33","author":"Brueckl","year":"2015","journal-title":"Am Soc Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.1","article-title":"Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers","volume":"108","author":"Lyratzopoulos","year":"2013","journal-title":"Br J Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ypmed.2019.05.001","article-title":"Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013\u20132017","volume":"124","author":"Warner","year":"2019","journal-title":"Prev Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06791-z","article-title":"Differences in the clinical management of women and men after detection of a solitary pulmonary nodule in clinical practice","volume":"30","author":"Chilet-Rosell","year":"2020","journal-title":"Eur Radiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2017.09.015","article-title":"Does gender matter? An analysis of men's and women's accounts of responding to symptoms of lung cancer","volume":"191","author":"MacLean","year":"2017","journal-title":"Soc Sci Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_391516","article-title":"Structural sexism and cancer care: the effects on the patient and oncologist","volume":"43","author":"Keenan","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2020.04.003","article-title":"Gender and lung cancer\u2014SEER-based analysis","volume":"46","author":"Tolwin","year":"2020","journal-title":"Ann Epidemiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2023.08.007","article-title":"Lung cancer in young patients is associated with more advanced disease but better overall survival","volume":"292","author":"Dingillo","year":"2023","journal-title":"J Surg Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cllc.2020.10.012","article-title":"Clinical and imaging features of non\u2013small-cell lung cancer in young patients","volume":"22","author":"Garrana","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7196\/AJTCCM.2020.v26i2.045","article-title":"The impact of age at presentation on lung cancer staging","volume":"26","author":"Mhlana","year":"2020","journal-title":"Afr J Thorac Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.3390\/cancers14246056","article-title":"Non-small cell lung cancer (NSCLC) in young adults, age< 50, is associated with late stage at presentation and a very poor prognosis in patients that do not have a targeted therapy option: a real-world study","volume":"14","author":"Hughes","year":"2022","journal-title":"Cancers"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.03.023","article-title":"Lung cancer in the very young: treatment and survival in the national cancer data base","volume":"11","author":"Arnold","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0761-8425(06)71461-9","article-title":"Epidemiology and delays in the management of 355 patients with lung cancer","volume":"23","author":"Virally","year":"2006","journal-title":"Rev Des maladies respiratoires"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.3390\/cancers13153711","article-title":"The role of surgery in lung cancer treatment: present indications and future perspectives\u2014state of the art","volume":"13","author":"Montagne","year":"2021","journal-title":"Cancers"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15300","article-title":"Surgical outcomes for non-small cell lung cancer in younger adults: A population-based study","volume":"15","author":"Zhang","year":"2024","journal-title":"Thorac Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5090\/jcs.21.105","article-title":"Current status of lung cancer and surgery based on studies using a nationwide database","volume":"55","author":"Kim","year":"2022","journal-title":"J Chest Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.xjon.2024.12.008","article-title":"Young lung cancer patients undergoing surgery: Comparison of clinicopathological characteristics and outcomes in patients aged\u2264 50 years versus> 50 years","volume":"24","author":"Leo","year":"2024","journal-title":"JTCVS Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2174\/18743064-v17-230818-2022-20","article-title":"Sex-specificity in surgical stages of lung cancer in young adults","volume":"17","author":"Abdennadher","year":"2023","journal-title":"Open Respir Med J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.21037\/jtd-22-210","article-title":"Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival","volume":"14","author":"Lee","year":"2022","journal-title":"J Thorac Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"100194","DOI":"10.1016\/j.jtocrr.2021.100194","article-title":"The genomics of young lung cancer: comprehensive tissue genomic analysis in patients under 40 with lung cancer","volume":"2","author":"Gitlitz","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.18.00216","article-title":"Lung cancer in young patients: higher rate of driver mutations and brain involvement, but better survival","volume":"5","author":"Suidan","year":"2019","journal-title":"J Global Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-018-1838-z","article-title":"Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger","volume":"20","author":"Pan","year":"2018","journal-title":"Clin Trans Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4482","article-title":"Association between younger age and targetable genomic alterations and prognosis in non\u2013small-cell lung cancer","volume":"2","author":"Sacher","year":"2016","journal-title":"JAMA Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02796-w","article-title":"Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review","volume":"24","author":"Guirado","year":"2022","journal-title":"Clin Trans Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1200\/OP.21.00485","article-title":"Impact of diagnostic delays on lung cancer survival outcomes: A population study of the US SEER-Medicare database","volume":"18","author":"Romine","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00338-7","article-title":"Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study","volume":"12","author":"Chang","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.09.085","article-title":"OA16. 04 preliminary results from the female Asian nonsmoker screening study (FANSS)","volume":"18","author":"Shum","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B57","article-title":"Lung-RADS","author":"Iranpour","year":"2024","journal-title":"Radiopaedia"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS3168","article-title":"The EQUAL study: Utilizing plasma EGFR cfDNA detection as an accessible screening tool for lung cancer in underserved patients ineligible for routine screening","volume":"43","author":"Narjust Florez","year":"2025","journal-title":"Am Soc Clin Oncol"},{"key":"B59","article-title":"USPSTF recommendations development process","year":"2021"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v149.4","article-title":"The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients","volume":"149","author":"Cai","year":"2021","journal-title":"Int J Cancer"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5978-5","article-title":"Molecular features of lung adenocarcinoma in young patients","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v123.10","article-title":"Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma","volume":"123","author":"Tanaka","year":"2017","journal-title":"Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136659","article-title":"Clinical features and gene mutations of lung cancer patients 30 years of age or younger","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.10","article-title":"Molecular features and clinical outcome of lung Malignancies in very young people","volume":"11","author":"Catania","year":"2015","journal-title":"Future Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.08.005","article-title":"Molecular alterations in non\u2013small cell lung carcinomas of the young","volume":"45","author":"VandenBussche","year":"2014","journal-title":"Hum Pathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v143.7","article-title":"Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers","volume":"143","author":"Luo","year":"2018","journal-title":"Int J Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181c41e8d","article-title":"Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis","volume":"5","author":"Subramanian","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/15384047.2019.1665392","article-title":"Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis","volume":"21","author":"Hou","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.esmoop.2020.100045","article-title":"Genomic profiling in non-small-cell lung cancer in young patients. A systematic review","volume":"6","author":"Vi\u00f1al","year":"2021","journal-title":"ESMO Open"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1413956","article-title":"Real-world comprehensive genomic and immune profiling reveals distinct age-and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer","volume":"15","author":"Wallen","year":"2024","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.3390\/cancers14102352","article-title":"Wide next-generation sequencing characterization of young adults non-small-cell lung cancer patients","volume":"14","author":"Ulivi","year":"2022","journal-title":"Cancers"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.792385","article-title":"The renaissance of KRAS targeting in advanced non-small-cell lung cancer: new opportunities following old failures","volume":"11","author":"Ferrara","year":"2021","journal-title":"Front Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"152407","DOI":"10.1016\/j.prp.2019.03.035","article-title":"Unique profiles of targetable genomic alterations and prognosis in young Chinese patients with lung adenocarcinoma","volume":"215","author":"Chen","year":"2019","journal-title":"Pathology-Research Pract"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000311","article-title":"Non\u2013small cell lung cancer in the very young: Higher EGFR\/ALK mutation proportion than the elder","volume":"83","author":"He","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"B75","first-page":"1031","article-title":"Comparison of clinicopathological and molecular features between young and old patients with lung cancer","volume":"11","author":"Zhong","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/diagnostics10080521","article-title":"Next generation sequencing for gene fusion analysis in lung cancer: a literature review","volume":"10","author":"Bruno","year":"2020","journal-title":"Diagnostics"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.03.39","article-title":"Genomic alterations and survival in young patients aged under 40 years with completely resected non-small cell lung cancer","volume":"7","author":"Yang","year":"2019","journal-title":"Ann Trans Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16730-7","article-title":"EGFR mutation rates correlate with age at diagnosis and tumor characteristics in patients with pulmonary ground-glass opacities","volume":"32","author":"Tang","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.v57.10","article-title":"Driver mutations of young lung adenocarcinoma patients with Malignant pleural effusion","volume":"57","author":"Wu","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00092-2016","article-title":"Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors","volume":"3","author":"Wu","year":"2017","journal-title":"ERJ Open Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0629","article-title":"Comprehensive molecular characterization of young Chinese patients with lung adenocarcinoma identified a distinctive genetic profile","volume":"23","author":"Hou","year":"2018","journal-title":"Oncologist"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.03.005","article-title":"High prevalence of somatic oncogenic driver alterations in patients with NSCLC and Li-Fraumeni syndrome","volume":"15","author":"Mezquita","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01372","article-title":"Germline EGFR mutations and familial lung cancer","volume":"41","author":"Oxnard","year":"2023","journal-title":"J Clin Oncol"},{"key":"B84","article-title":"The 23andMe lung cancer genetics study","year":"2024"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1108514","article-title":"EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1\u03b1 and STAT3","volume":"5","author":"Koh","year":"2016","journal-title":"Oncoimmunology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0336-3","article-title":"PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma","volume":"33","author":"Shen","year":"2020","journal-title":"Modern Pathol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.08.011","article-title":"STK11\/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive","volume":"157","author":"Di Federico","year":"2021","journal-title":"Eur J Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jtho.2021.10.013","article-title":"Diminished efficacy of programmed death-(ligand) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status","volume":"17","author":"Ricciuti","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2105","article-title":"KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden","volume":"31","author":"Marinelli","year":"2020","journal-title":"Ann Oncol"},{"key":"B90","article-title":"Biology of young lung cancer study: the YOUNG LUNG study","year":"","journal-title":"TrialX"},{"key":"B91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"New Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.478","article-title":"Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study","volume":"31","author":"Mok","year":"2020","journal-title":"Ann Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02278","article-title":"Post hoc analysis of lorlatinib intracranial efficacy and safety in patients with ALK-positive advanced non\u2013small-cell lung cancer from the phase III CROWN study","volume":"40","author":"Solomon","year":"2022","journal-title":"J Clin Oncol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.jtocrr.2022.100332","article-title":"Long-term efficacy and safety of entrectinib in ROS1 fusion\u2013positive NSCLC","volume":"3","author":"Drilon","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302299","article-title":"Repotrectinib in ROS1 Fusion\u2013positive non\u2013small-Cell lung cancer","volume":"390","author":"Drilon","year":"2024","journal-title":"New Engl J Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion\u2013positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"New Engl J Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.002","article-title":"Safety and efficacy of pralsetinib in RET fusion\u2013positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial","volume":"33","author":"Griesinger","year":"2022","journal-title":"Ann Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.01.69","article-title":"Clinicopathological characteristics and treatment strategies for young lung cancer patients","volume":"7","author":"Yoneyama","year":"2019","journal-title":"Ann Trans Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432488","article-title":"Tackling non\u2013small cell lung cancer in young adults: from risk factors and genetic susceptibility to lung cancer profile and outcomes","volume":"44","author":"Laguna","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.6901","article-title":"Association between age and survival trends in advanced non\u2013small cell lung cancer after adoption of immunotherapy","volume":"9","author":"Voruganti","year":"2023","journal-title":"JAMA Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.5.1232","article-title":"Lung cancer in patients< 50 years of age: the experience of an academic multidisciplinary program","volume":"115","author":"Gadgeel","year":"1999","journal-title":"Chest"},{"key":"B102","volume-title":"Surgery for oligometastatic non-small cell lung cancer","author":"Antonoff","year":"2023"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cllc.2019.07.007","article-title":"Improved overall survival with comprehensive local consolidative therapy in synchronous oligometastatic non\u2013small-cell lung cancer","volume":"21","author":"Mitchell","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezz384","article-title":"Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis","volume":"57","author":"Opitz","year":"2020","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11627-9","article-title":"Osimertinib, surgery, and radiation therapy in treating patients with stage IIIB or IV non-small cell lung cancer with EGFR mutations (NORTHSTAR)","volume":"29","author":"Khan","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2023.100065","article-title":"Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial","volume":"1","author":"Heeke","year":"2023","journal-title":"J Liquid Biopsy"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.03.011","article-title":"Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study","volume":"46","author":"de Rijke","year":"2004","journal-title":"Lung Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.1038\/s41598-021-86203-4","article-title":"Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China","volume":"11","author":"Shi","year":"2021","journal-title":"Sci Rep"},{"key":"B111","doi-asserted-by":"publisher","article-title":"FDA online label repository","year":"2025","DOI":"10.1056\/NEJMoa1713137"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"New Engl J Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306434","article-title":"Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC","volume":"389","author":"Planchard","year":"2023","journal-title":"New Engl J Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403614","article-title":"Amivantamab plus lazertinib for previously untreated EGFR-mutated advanced NSCLC","volume":"391","author":"Cho","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1200\/JCO.24.00533","article-title":"A multicenter open-label randomized phase II study of osimertinib with and without ramucirumab in tyrosine kinase inhibitor\u2013na\u00efve EGFR-mutant metastatic non\u2013small cell lung cancer (RAMOSE trial)","volume":"43","author":"Le","year":"2024","journal-title":"J Clin Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13223","article-title":"Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer","volume":"83","author":"Brown","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib versus crizotinib in patients with advanced ALK-positive non\u2013small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J Clin Oncol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.jtocrr.2023.100546","article-title":"Lorlatinib tolerability and association with clinical outcomes in patients with advanced ALK-or ROS1-rearranged NSCLC: A brief report","volume":"4","author":"Thummalapalli","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01365-3","article-title":"Consensus recommendations for management and counseling of adverse events associated with lorlatinib: a guide for healthcare practitioners","volume":"37","author":"Reed","year":"2020","journal-title":"Adv Ther"},{"key":"B120","article-title":"Accelerated approval for drug targeting NRG1","year":"2025"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.05.011","article-title":"NRG1 fusions: Biology to therapy","volume":"158","author":"Liu","year":"2021","journal-title":"Lung Cancer"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03307","article-title":"Clinicopathologic features and response to therapy of NRG1 fusion\u2013driven lung cancers: The eNRGy1 global multicenter registry","volume":"39","author":"Drilon","year":"2021","journal-title":"J Clin Oncol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0140-6736(21)00228-2","article-title":"Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial","volume":"397","author":"Sezer","year":"2021","journal-title":"Lancet"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for first-line treatment of PD-L1\u2013selected patients with NSCLC","volume":"383","author":"Herbst","year":"2020","journal-title":"New Engl J Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801946","article-title":"Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden","volume":"378","author":"Hellmann","year":"2018","journal-title":"New Engl J Med"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v10.3","article-title":"Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis","volume":"10","author":"Takamori","year":"2021","journal-title":"Cancer Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.11.011","article-title":"Impact of age on outcomes with immunotherapy in patients with non\u2013small cell lung cancer","volume":"14","author":"Lichtenstein","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non\u2013small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"New Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"New Engl J Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.10.014","article-title":"First-line nivolumab plus ipilimumab with chemotherapy versus chemotherapy alone for metastatic NSCLC in CheckMate 9LA: 3-year clinical update and outcomes in patients with brain metastases or select somatic mutations","volume":"18","author":"Paz-Ares","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejca.2019.08.027","article-title":"Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting","volume":"121","author":"Corbaux","year":"2019","journal-title":"Eur J Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.006","article-title":"Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis","volume":"45","author":"Nishijima","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0279","article-title":"Efficacy of immune checkpoint inhibitors in cancer patients of different ages: a meta-analysis","volume":"15","author":"Li","year":"2019","journal-title":"Future Oncol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1568810","article-title":"Correlation between patients\u2019 age and cancer immunotherapy efficacy","volume":"8","author":"Wu","year":"2019","journal-title":"Oncoimmunology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2217\/imt-2019-0124","article-title":"Efficacy of immune checkpoint inhibitors and age in cancer patients","volume":"12","author":"Huang","year":"2020","journal-title":"Immunotherapy"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB\u2013IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O'Brien","year":"2022","journal-title":"Lancet Oncol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non\u2013small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"New Engl J Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"New Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"107498","DOI":"10.1016\/j.intimp.2021.107498","article-title":"Immune-related adverse events associated with immune checkpoint inhibitors: an updated comprehensive disproportionality analysis of the FDA adverse event reporting system","volume":"95","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000871","article-title":"Impact of age on the toxicity of immune checkpoint inhibition","volume":"8","author":"Samani","year":"2020","journal-title":"J ImmunoTherapy Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13995","article-title":"Immune checkpoint inhibitor toxicity in 2018","volume":"320","author":"Johnson","year":"2018","journal-title":"JAMA"},{"key":"B144","article-title":"Early-life cancer diagnosis can have lasting psychological impact","author":"Lawrence","year":"2023","journal-title":"Med Bag"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00776-9","article-title":"Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship","volume":"20","author":"Lustberg","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0094","article-title":"Sex differences in tolerability to anti-programmed cell death protein 1 therapy in patients with metastatic melanoma and non-small cell lung cancer: are we all equal","volume":"24","author":"Duma","year":"2019","journal-title":"oncologist"},{"key":"B147","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12885-022-09421-7","article-title":"Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer\u2014is there a \u201ctail plateau\u201d in the survival curve of these patients","volume":"22","author":"Shimamura","year":"2022","journal-title":"BMC Cancer"},{"key":"B148","doi-asserted-by":"publisher","first-page":"S1556","DOI":"10.1016\/j.jtho.2025.04.010","article-title":"Overall survival in EGFR-mutant advanced non-small cell lung cancer treated with first-line osimertinib: A cohort study integrating clinical and biomarker data in the United States","author":"Sabari","year":"2025","journal-title":"J Thorac Oncol"},{"key":"B149","article-title":"Understanding young lung cancer: the time is now","author":"Narjust Florez","year":"2025"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.10.001","article-title":"Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress","volume":"55","author":"Graves","year":"2007","journal-title":"Lung Cancer"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.893","article-title":"Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data","volume":"18","author":"Hopwood","year":"2000","journal-title":"J Clin Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.50.4.383","article-title":"Mixed anxiety\/depression symptoms in a large cancer cohort: prevalence by cancer type","volume":"50","author":"Brintzenhofe-Szoc","year":"2009","journal-title":"Psychosomatics"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.7540","article-title":"Prevalence and predictors of the short-term trajectory of anxiety and depression in the first year after a cancer diagnosis: a population-based longitudinal study","volume":"31","author":"Boyes","year":"2013","journal-title":"J Clin Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v129.19","article-title":"Social isolation and social connectedness among young adult cancer survivors: A systematic review","volume":"129","author":"Fox","year":"2023","journal-title":"Cancer"},{"key":"B155","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/cncr.v130.23","article-title":"Social isolation, depression, and anxiety among young adult cancer survivors: The mediating role of social connectedness","volume":"130","author":"Li","year":"2024","journal-title":"Cancer"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.4236\/psych.2022.135055","article-title":"A study on the status and the correlation of stigma in young patients with lung cancer","volume":"13","author":"Li","year":"2022","journal-title":"Psychology"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2008.n.026","article-title":"Assessment of guilt and shame in patients with non\u2013small-cell lung cancer compared with patients with breast and prostate cancer","volume":"9","author":"LoConte","year":"2008","journal-title":"Clin Lung Cancer"},{"key":"B158","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000350834","article-title":"Lung cancer stigma, anxiety, depression and symptom severity","volume":"85","author":"Cataldo","year":"2013","journal-title":"Oncology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/pon.v24.11","article-title":"Psychological distress and quality of life in lung cancer: the role of health-related stigma, illness appraisals and social constraints","volume":"24","author":"Chambers","year":"2015","journal-title":"Psycho-Oncology"},{"key":"B160","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/pon.v23.1","article-title":"Stigma among patients with lung cancer: A patient-reported measurement model","volume":"23","author":"Hamann","year":"2014","journal-title":"Psycho-Oncology"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0026","article-title":"NCCN Guidelines\u00ae insights: distress management, version 2.2023: featured updates to the NCCN Guidelines","volume":"21","author":"Riba","year":"2023","journal-title":"J Natl Compr Cancer Network"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00293","article-title":"Management of anxiety and depression in adult survivors of cancer: ASCO guideline update","volume":"41","author":"Andersen","year":"2023","journal-title":"J Clin Oncol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"100507","DOI":"10.1016\/j.bbih.2022.100507","article-title":"The role of psychiatry in quality of life in young patients with non-small cell lung cancer","volume":"25","author":"Alpert","year":"2022","journal-title":"Brain Behavior Immunity-Health"},{"key":"B164","doi-asserted-by":"publisher","first-page":"21466","DOI":"10.1038\/s41598-022-25068-7","article-title":"Cognitive behavioral therapy for anxiety and depression in cancer survivors: a meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"B165","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.31557\/APJCP.2021.22.11.3455","article-title":"Effect of cognitive behavioral therapy on improving anxiety, depression, and quality of life in pre-diagnosed lung cancer patients","volume":"22","author":"Sutanto","year":"2021","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004282.pub3","article-title":"Non-invasive interventions for improving well-being and quality of life in patients with lung cancer","volume":"2011","author":"Rueda","year":"2011","journal-title":"Cochrane Database Systematic Rev"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s13187-017-1263-y","article-title":"Effects of a web-based health education program on quality of life and symptom distress of initially diagnosed advanced non-small cell lung cancer patients: a randomized controlled trial","volume":"34","author":"Huang","year":"2019","journal-title":"J Cancer Educ"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00857","article-title":"Integrative oncology care of symptoms of anxiety and depression in adults with cancer: society for integrative oncology\u2013ASCO guideline","volume":"41","author":"Carlson","year":"2023","journal-title":"J Clin Oncol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e2012598","DOI":"10.1001\/jamanetworkopen.2020.12598","article-title":"Association of mindfulness-based interventions with anxiety severity in adults with cancer: a systematic review and meta-analysis","volume":"3","author":"Oberoi","year":"2020","journal-title":"JAMA network Open"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1002\/pon.v28.12","article-title":"Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Cillessen","year":"2019","journal-title":"Psycho-oncology"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2055207620922381","DOI":"10.1177\/2055207620922381","article-title":"Evaluation of a web-based, tailored intervention to encourage help-seeking for lung cancer symptoms: a randomised controlled trial","volume":"6","author":"Mueller","year":"2020","journal-title":"Digital Health"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S9668","article-title":"A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults","volume":"2","author":"Novotny","year":"2010","journal-title":"Cancer Manage Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/cancers13102460","article-title":"Online, group-based psychological support for adolescent and young adult cancer survivors: results from the recapture life randomized trial","volume":"13","author":"Sansom-Daly","year":"2021","journal-title":"Cancers"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.12104","article-title":"Young lung cancer: Psychosocial needs assessment","volume":"42","author":"Florez","year":"2024","journal-title":"Am Soc Clin Oncol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004899","article-title":"Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes","volume":"95","author":"Esposito","year":"2016","journal-title":"Medicine"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.04.031","article-title":"Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: fertility risk of Food and Drug Administration\u2013approved systemic therapies","volume":"75","author":"Walter","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.esmoop.2021.100276","article-title":"Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review","volume":"6","author":"Garutti","year":"2021","journal-title":"ESMO Open"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0837","article-title":"It is time to talk about fertility and immunotherapy","volume":"25","author":"Duma","year":"2020","journal-title":"oncologist"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-021-02181-6","article-title":"Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review","volume":"38","author":"Rambhatla","year":"2021","journal-title":"J Assisted Reprod Genet"},{"key":"B180","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.theriogenology.2017.05.014","article-title":"Reversible meiotic arrest of bovine oocytes by EGFR inhibition and follicular hemisections","volume":"99","author":"da Rosa","year":"2017","journal-title":"Theriogenology"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.4149\/endo_2012_04_225","article-title":"Regulation of cumulus expansion and hyaluronan synthesis in porcine oocyte-cumulus complexes during in vitro maturation","volume":"46","author":"Nagyova","year":"2012","journal-title":"Endocr Regul"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v130.11","article-title":"When the unimaginable happens: Lung cancer diagnosis during pregnancy","volume":"130","author":"Florez","year":"2024","journal-title":"Cancer"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.09.569","article-title":"P3. 03I. 19 the international pregnancy and lung cancer registry at dana-farber cancer institute","volume":"19","author":"Florez","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900832","article-title":"Sexual inactivity results in reversible reduction of LH bioavailability","volume":"14","author":"Carosa","year":"2002","journal-title":"Int J impotence Res"},{"key":"B185","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.sxmr.2015.10.007","article-title":"Is testosterone a food for the brain","volume":"4","author":"Ciocca","year":"2016","journal-title":"Sexual Med Rev"},{"key":"B186","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.3390\/ijerph18179063","article-title":"Improving the sexual health of young people (under 25) in high-risk populations: a systematic review of behavioural and psychosocial interventions","volume":"18","author":"Brown","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00099-2","article-title":"What is sexual wellbeing and why does it matter for public health","volume":"6","author":"Mitchell","year":"2021","journal-title":"Lancet Public Health"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.08.011","article-title":"Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of US adults","volume":"13","author":"Flynn","year":"2016","journal-title":"J sexual Med"},{"key":"B189","article-title":"Correlates of symptom distress in women with lung cancer","volume":"1","author":"Sarna","year":"1993","journal-title":"Cancer Pract"},{"key":"B190","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00520-016-3415-8","article-title":"Lost and stranded: the experience of younger adults with advanced cancer","volume":"25","author":"Knox","year":"2017","journal-title":"Supportive Care Cancer"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1002\/pon.v20.4","article-title":"Sexual functioning along the cancer continuum: Focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS\u00ae)","volume":"20","author":"Flynn","year":"2011","journal-title":"Psycho-Oncology"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)54067-9","article-title":"Psychosocial distress and infertility: men and women respond differently","volume":"55","author":"Wright","year":"1991","journal-title":"Fertility sterility"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/BF00848324","article-title":"Coping and cognitive factors in adaptation to in vitro fertilization failure","volume":"15","author":"Litt","year":"1992","journal-title":"J Behav Med"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v130.3","article-title":"Sexual health assessment in women with lung cancer study: sexual health assessment in women with lung cancer","volume":"130","author":"Florez","year":"2024","journal-title":"Cancer"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.11.032","article-title":"Cancer survivorship: reproductive health outcomes should be included in standard toxicity assessments","volume":"144","author":"Anderson","year":"2021","journal-title":"Eur J Cancer"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2012.03368.x","article-title":"Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study","volume":"119","author":"Peddie","year":"2012","journal-title":"BJOG"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cllc.2023.10.007","article-title":"Lung cancer in women: the past, present, and future","volume":"25","author":"Florez","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae242","article-title":"From diagnosis to survivorship addressing the sexuality of women during cancer","volume":"29","author":"Kaufman","year":"2024","journal-title":"Oncologist"},{"key":"B199","article-title":"Disparities in cancer survivorship","year":"2022"},{"key":"B200","article-title":"Case for federal fertility preservation coverage","year":"2021"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.2780","article-title":"A geospatial analysis of disparities in access to oncofertility services","volume":"9","author":"Peipert","year":"2023","journal-title":"JAMA Oncol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.5046","article-title":"Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial","volume":"35","author":"Temel","year":"2017","journal-title":"J Clin Oncol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12904-023-01327-w","article-title":"Factors related to advance directives completion among cancer patients: a systematic review","volume":"23","author":"Golmohammadi","year":"2024","journal-title":"BMC Palliative Care"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac211","article-title":"End-of-life care and advanced directives in Hispanic\/Latinx patients: challenges and solutions for the practicing oncologist","volume":"27","author":"Barragan-Carrillo","year":"2022","journal-title":"Oncologist"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3","article-title":"Comparative effectiveness trial of early palliative care delivered via telehealth versus in person among patients with advanced lung cancer","volume":"42","author":"Greer","year":"2024","journal-title":"Am Soc Clin Oncol"},{"key":"B206","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2024.10398","article-title":"Stepped palliative care for patients with advanced lung cancer: A randomized clinical trial","volume":"332","author":"Temel","year":"2024","journal-title":"JAMA"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02596","article-title":"Cannabis and cannabinoids in adults with cancer: ASCO guideline","volume":"42","author":"Braun","year":"2024","journal-title":"J Clin Oncol"},{"key":"B208","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1016\/S2468-2667(24)00223-8","article-title":"Cancer risk and legalisation of access to cannabis in the USA: overview of the evidence","volume":"10","author":"Nargis","year":"2024","journal-title":"Lancet Public Health"},{"key":"B209","doi-asserted-by":"publisher","first-page":"715","DOI":"10.6004\/jnccn.2023.7021","article-title":"A pilot randomized trial of an advance care planning video decision support tool for adolescents and young adults with advanced cancer","volume":"21","author":"Snaman","year":"2023","journal-title":"J Natl Compr Cancer Network"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.974","article-title":"Barriers to the composition and implementation of advance directives in oncology: a literature review","volume":"13","author":"Buiar","year":"2019","journal-title":"ecancermedicalscience"},{"key":"B211","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2018.06.012","article-title":"Advance care planning and end-of-life decision making for patients with cancer","volume-title":"Seminars in oncology nursing","author":"Agarwal","year":"2018"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.14.1665","article-title":"Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment","volume":"300","author":"Wright","year":"2008","journal-title":"JAMA"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:28:46Z","timestamp":1750915726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":212,"alternative-id":["10.3389\/fonc.2025.1570143"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1570143","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"article-number":"1570143"}}